Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
87.36
+3.43 (4.09%)
At close: Aug 13, 2025, 4:00 PM
85.61
-1.75 (-2.00%)
Pre-market: Aug 14, 2025, 9:04 AM EDT
Inspire Medical Systems Revenue
Inspire Medical Systems had revenue of $217.09M in the quarter ending June 30, 2025, with 10.82% growth. This brings the company's revenue in the last twelve months to $861.31M, up 22.05% year-over-year. In the year 2024, Inspire Medical Systems had annual revenue of $802.80M with 28.49% growth.
Revenue (ttm)
$861.31M
Revenue Growth
+22.05%
P/S Ratio
3.02
Revenue / Employee
$691,262
Employees
1,246
Market Cap
2.58B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 802.80M | 178.01M | 28.49% |
Dec 31, 2023 | 624.80M | 216.94M | 53.19% |
Dec 31, 2022 | 407.86M | 174.46M | 74.75% |
Dec 31, 2021 | 233.39M | 118.01M | 102.28% |
Dec 31, 2020 | 115.38M | 33.33M | 40.62% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
INSP News
- 2 days ago - INSP Investors Have Opportunity to Join Inspire Medical Systems, Inc. Fraud Investigation with the Schall Law Firm - PRNewsWire
- 3 days ago - Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program - GlobeNewsWire
- 3 days ago - Baron Discovery Fund Q2 2025: Winners And Setbacks Shaping The Portfolio - Seeking Alpha
- 6 days ago - Inspire Medical Stock Strays Off Course Amid Structural Setback - Benzinga
- 7 days ago - Inspire Medical Systems, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 8 days ago - Inspire Medical Systems Analysts Lower Their Forecasts After Q2 Results - Benzinga
- 8 days ago - Inspire Medical Plunges On Outlook Cut, Weak V System Rollout: Analysts React - Benzinga
- 8 days ago - Inspire Medical Systems, Inc. Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm's Investigation - GlobeNewsWire